CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
The SPRAY-CB trial marks the first pivotal study of a medical device therapy targeting the underlying cause of Chronic Bronchitis
BOSTON, Oct. 22, 2020 -- (Healthcare Sales & Marketing Network) -- CSA Medical Inc., a developer of medical devices advanc... Devices CSA Medical, cryotherapy, RejuvenAir System, COPD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Bronchitis | Chronic Obstructive Pulmonary | Cryotherapy | Marketing | Medical Devices | Pharmaceuticals | Study